Hengdian Pharmaceutical Industry (stock code 301211.SZ) mainly engages in the research and development, production, and sales of chemical active pharmaceutical ingredients (including intermediates) and formulated products.

Gelonghui Finance · Aug 5, 2024 07:30

Hengdian Pharmaceutical (301211.SZ) announced on August 5 that the company is mainly engaged in the research and development, production and sales of chemical raw materials (including intermediates) and formulated products, and can provide contract research and development and production services (CDMO) according to customer needs. Contract research and development and production services (CDMO) include intermediates, key starting materials and active pharmaceutical ingredients, meeting customers' different needs from pre-clinical to commercialization stages such as process research and development, pilot testing, commercial production, method validation and registration declaration.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

Recommended

Write a comment

Discussing

Chinese stock earnings surge: Will profit sustain the rally?

1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More

Can strong earnings reports drive Chinese concept stocks to continue rising?

78%

22%

Bullish

Bearish

1571 votes

Moomoo News Global

Mar 4 15:26

China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings

On Tuesday, China's political leadership is convening at the Great Hall of the People in Beijing for the year's most significant event, known as the "Two Sessions." These closed-door meetings are the annual plenary sessions of both the National People's Congress and the Chinese People's Political Consultative Conference, typically held simultaneously in March. The sessions generally last for about ten days....

亨迪药业(301211.SZ)：主要从事化学原料药（含中间体）及制剂产品的研发、生产和销售

Hengdian Pharmaceutical Industry (stock code 301211.SZ) mainly engages in the research and development, production, and sales of chemical active pharmaceutical ingredients (including intermediates) and formulated products.

Market Insights

Discussing

Discussing

亨迪药业(301211.SZ)：主要从事化学原料药（含中间体）及制剂产品的研发、生产和销售

Hengdian Pharmaceutical Industry (stock code 301211.SZ) mainly engages in the research and development, production, and sales of chemical active pharmaceutical ingredients (including intermediates) and formulated products.

Risk Disclaimer

Market Insights

Discussing

Discussing

Statement